Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
The coronavirus disease 2019 (COVID-19) pandemic has caused considerable socio-economic burden, which fueled the development of treatment strategies and vaccines at an unprecedented speed. However, our knowledge on disease recovery is sparse and concerns about long-term pulmonary impairments are inc...
Main Authors: | Mirjam Kiener, Nuria Roldan, Carlos Machahua, Arunima Sengupta, Thomas Geiser, Olivier Thierry Guenat, Manuela Funke-Chambour, Nina Hobi, Marianna Kruithof-de Julio |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.644678/full |
Similar Items
-
Impaired Wound Healing of Alveolar Lung Epithelial Cells in a Breathing Lung-On-A-Chip
by: Marcel Felder, et al.
Published: (2019-01-01) -
Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
by: Martina Minoli, et al.
Published: (2020-08-01) -
Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies
by: Anke Schertel, et al.
Published: (2017-11-01) -
Evaluation of a Novel Ear Pulse Oximeter: Towards Automated Oxygen Titration in Eyeglass Frames
by: Fabian Braun, et al.
Published: (2020-06-01) -
Serum metabolic profiling identified a distinct metabolic signature in patients with idiopathic pulmonary fibrosis – a potential biomarker role for LysoPC
by: Barbara Rindlisbacher, et al.
Published: (2018-01-01)